Subscribe
Pet Health & Wellness
8 min read

The New Frontier of Preventive Pet Care

Three founders building the early-detection layer of pet health sit down with The Underbite: Rhett Rumery of Tether (wearable pain monitoring for dogs), William von der Pahlem of DeepScan Diagnostics (cell-free DNA cancer screening), and Fayzan Chaudry of Everfur (metabolomics fur testing plus a pet health app). They explain why veterinary medicine stays reactive, how long disease hides before symptoms appear, and why continuous longitudinal monitoring could move pet-care spend earlier over the next decade.

Written by
Roy Ben-Tzvi
Published on
October 27, 2026
Three founders on the new frontier of preventive pet care

For decades, veterinary medicine has largely operated reactively. A dog limps, stops eating, develops visible symptoms - and only then does treatment begin. But a new wave of founders believes the biggest opportunity in pet health isn't treating disease later. It's detecting it earlier. Much earlier.

In this conversation, the founders of Tether, DeepScan Diagnostics, and Everfur break down how wearables, biomarkers, AI, metabolomics, and longitudinal health tracking could fundamentally reshape pet care over the next decade. From silent cancers and chronic pain to metabolic changes hidden beneath the surface, these companies are building tools designed to catch what owners and even veterinarians often cannot see — until it's too late.

Rhett Rumery - co-founder & CEO at Tether

Rhett Rumery, co-founder and CEO at Tether
Rhett Rumery, co-founder and CEO at Tether

For readers unfamiliar with Tether, what exactly does the company do, and what problem in pet health are you trying to solve?

Rhett Rumery, Tether: My dog Söze was diagnosed with degenerative myelopathy too late to intervene. After his diagnosis, I went back through everything, the videos, the photos, the way he had been moving for months, and I realized he had been in pain long before I caught it. I missed it. He hid it the way dogs do, so I couldn't see the drift. That's the moment Tether started.

Tether is a preventive health intelligence company for dogs. We built a wearable called the Ruff that monitors a dog's vitals, movement, and behavior in the background and surfaces patterns related to pain. Dogs hide pain and decline, and most owners and vets only catch it once the underlying disease is already advanced. The Ruff detects pain, contextualizes it against the dog's own personal baseline, breed, age, and environment, then tells the owner and the vet what to do next. Recommendations, not raw numbers. That intelligence layer is something neither pet parents nor vets have ever had.

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

Pro
Keep Reading

Other Interviews

More conversations with founders, operators, and investors building the future of pet care.

Learn more
Deven Vespi | Advisor, DRV Advisory
Pet Health & Wellness
13 min read

Deven Vespi | Advisor, DRV Advisory

Clinically proven has no shared definition in pet, yet it now shapes deals as much as labels. Deven Vespi learned the trade in FDA-regulated animal health, and she explains how to check a study before you trust it or build a deal on it. She covers sample sizes, dosing gaps, why brands get blindsided by their own research, and how long published data stays an edge.

Learn more
Learn more
Meet the Founders: 3 Startups Shaping the Future of Pet Health
Pet Health & Wellness
10 min read

Meet the Founders: 3 Startups Shaping the Future of Pet Health

Pawsible Ventures took seven of more than 130 applicants into its second cohort. Three of them work very different corners of pet health. Nicole Shlomof and Gila Leibovitch of Pawp Water sell functional water to owners who already fill the bowl, Andria Beal of EpiPaws turned dolphin epigenetics research into biological-age tests for dogs and cats, and Elliot Greenwood of ChckVet sells software to vet practices that resist new tech.

Learn more
Learn more
Elizabeth Iorns | Co-Founder & CEO, Familiar Therapeutics
Pet Health & Wellness
17 min read

Elizabeth Iorns | Co-Founder & CEO, Familiar Therapeutics

Elizabeth Iorns lost her French Bulldog to a brain tumor that a published canine study suggested could be treated, but no company had taken the drug forward for dogs. Now she and Science Exchange co-founder Dan Knox license the companion animal rights to human drugs at Familiar Therapeutics: 13 programs and $5 million raised in five months, plus a pitch to pharma that pet trials validate targets faster than phase two.

Learn more
View all interviews